Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850
Farrell C, Shi W, Bodman A, Olson JJ (2020) Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma. J Neuro-Oncol 150:269–359
Nayak L, Reardon DA (2017) High-grade gliomas. CONTINUUM Lifelong Learn Neurol 23:1548–1563
Hervey-Jumper SL, Berger MS (2016) Maximizing safe resection of low- and high-grade glioma. J Neuro-Oncol 130:269–282
Duffau H (2016) Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up. Acta Neurochir 158:51–58. https://doi.org/10.1007/s00701-015-2621-3
Almeida JP, Chaichana KL, Rincon-Torroella J, Quinones-Hinojosa A (2015) The value of extent of resection of glioblastomas: clinical evidence and current approach. Curr Neurol Neurosci Rep 15:517
Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198. https://doi.org/10.3171/jns.2001.95.2.0190
McGirt MJ, Chaichana KL, Gathinji M et al (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma: clinical article. J Neurosurg 110:156–162. https://doi.org/10.3171/2008.4.17536
Sanai N, Polley MY, McDermott MW et al (2011) An extent of resection threshold for newly diagnosed glioblastomas: clinical article. J Neurosurg 115:3–8. https://doi.org/10.3171/2011.2.JNS10998
Brown TJ, Brennan MC, Li M et al (2016) Association of the extent of resection with survival in glioblastoma a systematic review and meta-analysis. JAMA Oncol 2:1460–1469. https://doi.org/10.1001/jamaoncol.2016.1373
Michael Y, Hess K (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection? J Neurosurg 124:977–988. https://doi.org/10.3171/2015.5.JNS142087
Albert FK, Forsting M, Sartor K et al (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45–61. https://doi.org/10.1097/00006123-199401000-00008
Berger MS (1994) Malignant astrocytomas: surgical aspects. Semin Oncol 21:172–185
Kelly PJ, Daumas-Duport C, Kispert DB et al (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865–874. https://doi.org/10.3171/jns.1987.66.6.0865
Jbabdi S, Mandonnet E, Duffau H et al (2005) Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging. Magn Reson Med 54:616–624. https://doi.org/10.1002/mrm.20625
Pallud J, Varlet P, Devaux B et al (2010) Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology 74:1724–1731. https://doi.org/10.1212/WNL.0b013e3181e04264
Yordanova YN, Moritz-Gasser S, Duffau H (2011) Awake surgery for WHO grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection: clinical article. J Neurosurg 115:232–239. https://doi.org/10.3171/2011.3.JNS101333
Shah AH, Mahavadi A, Di L et al (2020) Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection. J Neuro-Oncol 148:501–508. https://doi.org/10.1007/s11060-020-03541-5
Daniels TB, Brown PD, Felten SJ et al (2011) Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 81:218–224. https://doi.org/10.1016/j.ijrobp.2010.05.003
Shields LBE, Choucair AK (2014) Management of low-grade gliomas: a review of patient-perceived quality of life and neurocognitive outcome. World Neurosurg 82:e299–e309
Jackson C, Choi J, Khalafallah AM et al (2020) A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma. J Neuro-Oncol 148:419–431
Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection? J Neurosurg 124:977–988. https://doi.org/10.3171/2015.5.JNS142087
Pessina F, Navarria P, Cozzi L et al (2017) Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neuro-Oncol 135:129–139. https://doi.org/10.1007/s11060-017-2559-9
Glenn CA, Baker CM, Conner AK et al (2018) An examination of the role of supramaximal resection of temporal lobe glioblastoma multiforme. World Neurosurg 114:747
Aldave G, Tejada S, Pay E et al (2013) Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurgery 72:915–921. https://doi.org/10.1227/NEU.0b013e31828c3974
Esquenazi Y, Friedman E, Tandon N et al (2015) The survival advantage of “supratotal” resection of glioblastoma using selective cortical mapping and the subpial technique tractography view project advanced brain tumor imaging view project the survival advantage of “supratotal.” Resection Glioblastom. https://doi.org/10.1093/neuros/nyw174
Eyüpoglu IY, Hore N, Merkel A et al (2016) Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma. Oncotarget 7:25755–25768. https://doi.org/10.18632/oncotarget.8367
Roh TH, Kang SG, Moon JH et al (2020) Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: A retrospective study. J Neurosurg 132:895–901. https://doi.org/10.3171/2018.12.JNS182558
Daigle K, Fortin D, Mathieu D, Saint-Pierre AB, Paré FM, de la Sablonnière A, Goffaux P (2013) Effects of surgical resection on the evolution of quality of life in newly diagnosed patients with glioblastoma: a report on 19 patients surviving to follow-up. Curr Med Res Opin 29(10):1307–1313. https://doi.org/10.1185/03007995.2013.823858
Jakola AS, Unsgå G, Solheim O (2011) Quality of life in patients with intracranial gliomas: the impact of modern image-guided surgery. Clinical article. J Neurosurg 114:1622–1630. https://doi.org/10.3171/2011.1.JNS101657
Brown PD, Maurer MJ, Rummans TA et al (2005) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495–503. https://doi.org/10.1227/01.NEU.0000170562.25335.C7
Jakola AS, Gulati S, Weber C et al (2011) Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study. PLoS ONE. https://doi.org/10.1371/journal.pone.0028592
Peters KB, West MJ, Hornsby WE et al (2014) Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. J Neuro-Oncol 120:499–506. https://doi.org/10.1007/s11060-014-1574-3
Rahman M, Abbatematteo J, de Leo EK et al (2017) The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. J Neurosurg 127:123–131. https://doi.org/10.3171/2016.7.JNS16396
Wolf J, Campos B, Bruckner T et al (2016) Evaluation of neuropsychological outcome and “quality of life” after glioma surgery. Langenbeck’s Arch Surg 401:541–549. https://doi.org/10.1007/s00423-016-1403-6
Talacchi A, Santini B, Savazzi S, Gerosa M (2011) Cognitive effects of tumour and surgical treatment in glioma patients. J Neuro-Oncol 103:541–549. https://doi.org/10.1007/s11060-010-0417-0
Habets EJ, Kloet A, Walchenbach R, Vecht CJ, Klein M, Taphoorn MJ (2014) Tumour and surgery effects on cognitive functioning in high-grade glioma patients. Acta Neurochir 156(8):1451–1459. https://doi.org/10.1007/s00701-014-2115-8
Ng J, See A, Ang TY, Tan L, Ang BT, King N (2019) Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes. J Neuro-oncol 141(1):167–182. https://doi.org/10.1007/s11060-018-03023-9
Altieri R, Raimondo S, Tiddia C et al (2019) Glioma surgery: from preservation of motor skills to conservation of cognitive functions. J Clin Neurosci 70:55–60. https://doi.org/10.1016/j.jocn.2019.08.091
van Loenen IS, Rijnen S, Bruijn J, Rutten GM, Gehring K, Sitskoorn MM (2018) Group changes in cognitive performance after surgery mask changes in individual patients with glioblastoma. World Neurosurg 117:e172–e179. https://doi.org/10.1016/j.wneu.2018.05.232
Barzilai O, ben Moshe S, Sitt R et al (2019) Improvement in cognitive function after surgery for low-grade glioma. J Neurosurg 130:426–434. https://doi.org/10.3171/2017.9.JNS17658
Gibb WR, Kong NW, Tate MC (2020) Direct evidence of plasticity within human primary motor and somatosensory cortices of patients with glioblastoma. Neural Plast. https://doi.org/10.1155/2020/8893708
Péus D, Newcomb N, Hofer S (2013) Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation. BMC Med Inf Decis Making 13:72
Patel CK, Vemaraju R, Glasbey J, Shires J, Northmore T, Zaben M, Hayhurst C (2018) Trends in peri-operative performance status following resection of high grade glioma and brain metastases: the impact on survival. Clin Neurol Neurosurg 164:67–71. https://doi.org/10.1016/j.clineuro.2017.11.016
Zarino B, Di Cristofori A, Fornara GA, Bertani GA, Locatelli M, Caroli M, Rampini P, Cogiamanian F, Crepaldi D, Carrabba G (2020) Long-term follow-up of neuropsychological functions in patients with high grade gliomas: can cognitive status predict patient’s outcome after surgery? Acta Neurochir 162(4):803–812. https://doi.org/10.1007/s00701-020-04230-y
Grabowski MM, Recinos PF, Nowacki AS et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121:1115–1123
Mampre D, Ehresman J, Pinilla-Monsalve G, Osorio MAG, Olivi A, Quinones-Hinojosa A, Chaichana KL (2016) Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes. British J Neurosurg 32(5):528–535
De Bonis P, Anile C, Pompucci A, Fiorentino A, Balducci M, Chiesa S, Lauriola L, Maira G, Mangiola A (2013) The influence of surgery on recurrence pattern of glioblastoma. Clin Neurol Neurosurg 115(1):37–43
Hamada SM, Abou-Zeid AH (2016) Anatomical resection in glioblastoma: extent of resection and its impact on duration of survival. Egypt J Neurol Psychiatry Neurosurg 53(3):135
Esquenazi Y, Friedman E, Liu Z, Zhu J-J, Hsu S, Tandon N (2017) The survival advantage of “supratotal” resection of glioblastoma using selective cortical mapping and the subpial technique. Neurosurgery 81(2):275–288
Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Kimchi TJ, Harosh CB, Ram Z (2017) Dynamics of FLAIR volume changes in glioblastoma and prediction of survival. Ann Surg Oncol 24(3):794–800